Indoco Remedies in preliminary discussions to sell part of domestic business: Report

17 Jan 2019 Evaluate

Indoco Remedies is reportedly to sell part of its domestic business for Rs 500-600 crore. Regarding this, the company is in preliminary discussions with investors such as Zydus Cadila and Lupin, along with TPG Capital Management and Temasek Holdings. This transaction will help the company to focus on its high-margin global businesses.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.25 -0.65 (-0.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×